GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Icure Pharmaceutical Inc (XKRX:175250) » Definitions » PB Ratio

Icure Pharmaceutical (XKRX:175250) PB Ratio : 1.35 (As of May. 28, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Icure Pharmaceutical PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-28), Icure Pharmaceutical's share price is ₩1932.00. Icure Pharmaceutical's Book Value per Share for the quarter that ended in Mar. 2024 was ₩1,433.35. Hence, Icure Pharmaceutical's PB Ratio of today is 1.35.

The historical rank and industry rank for Icure Pharmaceutical's PB Ratio or its related term are showing as below:

XKRX:175250' s PB Ratio Range Over the Past 10 Years
Min: 0.9   Med: 2.5   Max: 22.95
Current: 1.35

During the past 10 years, Icure Pharmaceutical's highest PB Ratio was 22.95. The lowest was 0.90. And the median was 2.50.

XKRX:175250's PB Ratio is ranked better than
65.14% of 958 companies
in the Drug Manufacturers industry
Industry Median: 1.97 vs XKRX:175250: 1.35

During the past 12 months, Icure Pharmaceutical's average Book Value Per Share Growth Rate was -35.00% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -29.80% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -18.20% per year.

During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Icure Pharmaceutical was 98.50% per year. The lowest was -29.80% per year. And the median was 28.95% per year.

Back to Basics: PB Ratio


Icure Pharmaceutical PB Ratio Historical Data

The historical data trend for Icure Pharmaceutical's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Icure Pharmaceutical PB Ratio Chart

Icure Pharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.34 4.17 3.56 1.06 1.34

Icure Pharmaceutical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.85 1.34 1.06 1.34 1.41

Competitive Comparison of Icure Pharmaceutical's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Icure Pharmaceutical's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Icure Pharmaceutical's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Icure Pharmaceutical's PB Ratio distribution charts can be found below:

* The bar in red indicates where Icure Pharmaceutical's PB Ratio falls into.



Icure Pharmaceutical PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Icure Pharmaceutical's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=1932.00/1433.35
=1.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Icure Pharmaceutical  (XKRX:175250) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Icure Pharmaceutical PB Ratio Related Terms

Thank you for viewing the detailed overview of Icure Pharmaceutical's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Icure Pharmaceutical (XKRX:175250) Business Description

Traded in Other Exchanges
N/A
Address
7, Saimdang-ro 1-gil, Seocho-gu, Seoul, KOR
Icure Pharmaceutical Inc operates as a biopharmaceutical company engages in the development and commercialization of novel transdermal drug delivery formulation. It also developed and commercialized various patches and hydrogels for the treatment of rheumatic arthritis pain, nicotine replacement therapy, medicated wound dressings, skin care, and dental care. The products pipeline is also aimed at the development of prescription drugs to diseases of the central nervous system, asthma, and pain.

Icure Pharmaceutical (XKRX:175250) Headlines

No Headlines